SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a new all-time high or if it is entering a period of exhaustion. Bullish traders are actively calling for others to hold through dips and push for higher volume, while skeptics warn of potential rug pulls and shift their attention to emerging meme coins.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and trending momentum as investors closely monitor upcoming blockchain upgrades and potential token burn events. The community remains deeply divided, with many traders speculating on a supply shock and potential price recovery while skeptics warn of pump-and-dump risks.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending due to excitement surrounding its electro-optic polymer technology, with investors actively discussing potential integration into data centers and high-speed AI infrastructure through partnerships. The community remains highly focused on monitoring for commercialization catalysts and significant contract announcements, while debating the stock's valuation as it experiences increased trading volume and volatility.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The $ROAR token is seeing intense community-driven momentum as investors draw parallels between its community-led project model and the broader GameStop market sentiment. Discussions are dominated by speculation regarding potential exchange listings and the ongoing strength of the Roaring Kitty narrative, with holders emphasizing the project's decentralized, community-owned structure.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating strong community interest driven by its position as a key infrastructure layer for AI-integrated blockchain applications and its rising utility in cross-chain intents. Traders are actively discussing the protocol's fundamental strength and price compression as a potential setup for an upward breakout.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a preliminary Phase 3 trial design for its CAD-1005 program for Heparin-Induced Thrombocytopenia, marking a key milestone after end-of-Phase 2 FDA meetings. While supporters point to the potential of its cardiovascular pipeline and Orphan Drug designations as catalysts, community sentiment remains deeply divided as critics raise concerns regarding consistent bot-driven spam and the company's historical reliance on dilutive capital raises.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's 'move-to-earn' utility and potential for a future breakout. Despite recent downward pressure, many supporters are actively accumulating while highlighting their commitment to the ecosystem's long-term growth and fitness-focused mission.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is currently a focal point for investors as the company navigates a critical FDA appeal process for its spinocerebellar ataxia therapy, with the community actively speculating on the impact of recent leadership changes at the FDA on potential drug re-reviews. Discussions are dominated by the search for a new path forward following a prior rejection, balanced against strong institutional positioning and institutional conviction that the company's broader pipeline remains significantly undervalued.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

The JPMorgan Equity Premium Income ETF ($JEPI) remains a central focus for income-oriented investors, with recent community sentiment driven by its ability to provide monthly cash flow distributions amid broader market volatility. Investors are actively discussing the strategy's utility as a portfolio stabilizer and income generator, often comparing it to $JEPQ and other derivative-income funds to evaluate trade-offs between yield, tax treatment, and capital preservation.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is trending as investors debate the project's long-term utility against its recent lackluster price performance and declining market cap ranking. Community discussion is sharply divided between believers accumulating tokens in anticipation of network upgrades and long-term ecosystem development, and vocal skeptics frustrated by the lack of upward momentum compared to other altcoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Downgrades Sharps Technology (NASDAQ:STSS) to Sell

Wall Street Zen lowered Sharps Technology from a "hold" rating to a "sell" rating in a research report on Saturday...

Sharps Technology, Inc. (NASDAQ:STSS) Sees Significant Increase in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totaling 626,239 shares, an increase of 22.0...

Sharps Technology (NASDAQ:STSS) Stock Price Down 4.8% - Time to Sell?

Sharps Technology (NASDAQ:STSS) Trading Down 4.8% - What's Next...

Sharps Technology (STSS) Expected to Announce Quarterly Earnings on Thursday

Sharps Technology (NASDAQ:STSS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-sharps-technology-inc-stock...

Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 516,282 shares, a...

Holdings Ltd Falconx Sells 239,588 Shares of Sharps Technology (NASDAQ:STSS) Stock

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) major shareholder Holdings Ltd Falconx sold 239,588 shares of Sharps Technology stock in a transaction dated Monday, January 12th. The shares...

Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 32.5% in January

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totaling 562,865 shares, a...

Saba Capital Management, L.P. Sells 12,182 Shares of Sharps Technology (NASDAQ:STSS) Stock

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) major shareholder Saba Capital Management, L.P. sold 12,182 shares of the firm's stock in a transaction dated Friday, January 16th. The stock...

Saba Capital Management, L.P. Sells 25,000 Shares of Sharps Technology (NASDAQ:STSS) Stock

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) major shareholder Saba Capital Management, L.P. sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, January...

Sharps Technology (NASDAQ:STSS) Major Shareholder Saba Capital Management, L.P. Sells 12,182 Shares

Sharps Technology, Inc. (NASDAQ:STSS - Get Free Report) major shareholder Saba Capital Management, L.P. sold 12,182 shares of the stock in a transaction dated Friday, January 16th. The stock was sold...

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

Current Price	$1.84
Prev Close	$1.79
Open	$1.77
Dividend Yield	0.00%
50-Day Moving Average	$1.78
Beta	1.15
Avg. Volume	389,342.08
PE Ratio	0.06

52-Week High	$18.23
52-Week Low	$1.42
Market Capitalization	$71.14M
EPS (Annual)	-$11.12
Price to Book	0.20
Revenue Per Employee	N/A

STSS
Sharps Technology Inc

Feed

News

Sentiment

Fundamentals

Info

Latest STSS News

STSSSharps Technology Inc